Year
DEALS // DEV.
Country
Therapeutic Area
Study Phase
Deal Type
Product Type
Dosage Form
Lead Product
Target
Lead Product(s) : Eplerenone
Therapeutic Area : Undisclosed
Study Phase : Phase I
Sponsor : ACDIMA Biocenter
Deal Size : Inapplicable
Deal Type : Inapplicable
Details : Undisclosed
Product Name : Undisclosed
Product Type : Other Small Molecule
Upfront Cash : Inapplicable
December 23, 2022
Lead Product(s) : Eplerenone
Therapeutic Area : Undisclosed
Highest Development Status : Phase I
Sponsor : ACDIMA Biocenter
Deal Size : Inapplicable
Deal Type : Inapplicable
Lead Product(s) : Eplerenone
Therapeutic Area : Cardiology/Vascular Diseases
Study Phase : Phase II
Sponsor : British Heart Foundation | Abbott Laboratories
Deal Size : Inapplicable
Deal Type : Inapplicable
Stratified Medicine of Eplerenone in Acute MI/injury (StratMed-MINOCA)
Details : Undisclosed
Product Name : Undisclosed
Product Type : Other Small Molecule
Upfront Cash : Inapplicable
January 20, 2022
Lead Product(s) : Eplerenone
Therapeutic Area : Cardiology/Vascular Diseases
Highest Development Status : Phase II
Sponsor : British Heart Foundation | Abbott Laboratories
Deal Size : Inapplicable
Deal Type : Inapplicable
Lead Product(s) : Eplerenone
Therapeutic Area : Ophthalmology
Study Phase : Phase II
Sponsor : Oxurion
Deal Size : Inapplicable
Deal Type : Inapplicable
Details : Undisclosed
Product Name : Undisclosed
Product Type : Other Small Molecule
Upfront Cash : Inapplicable
March 09, 2020
Lead Product(s) : Eplerenone
Therapeutic Area : Ophthalmology
Highest Development Status : Phase II
Sponsor : Oxurion
Deal Size : Inapplicable
Deal Type : Inapplicable
Lead Product(s) : Eplerenone
Therapeutic Area : Undisclosed
Study Phase : Phase I
Sponsor : Inapplicable
Deal Size : Inapplicable
Deal Type : Inapplicable
Pharmacokinetics Study of Eplerenone Coated Tablets
Details : Undisclosed
Product Name : Undisclosed
Product Type : Other Small Molecule
Upfront Cash : Inapplicable
November 06, 2016
Lead Product(s) : Eplerenone
Therapeutic Area : Undisclosed
Highest Development Status : Phase I
Sponsor : Inapplicable
Deal Size : Inapplicable
Deal Type : Inapplicable
Lead Product(s) : Eplerenone
Therapeutic Area : Undisclosed
Study Phase : Phase I
Sponsor : Inapplicable
Deal Size : Inapplicable
Deal Type : Inapplicable
Pharmacokinetics of Eplerenone Tablet
Details : Undisclosed
Product Name : Undisclosed
Product Type : Other Small Molecule
Upfront Cash : Inapplicable
November 18, 2015
Lead Product(s) : Eplerenone
Therapeutic Area : Undisclosed
Highest Development Status : Phase I
Sponsor : Inapplicable
Deal Size : Inapplicable
Deal Type : Inapplicable
Lead Product(s) : Eplerenone
Therapeutic Area : Cardiology/Vascular Diseases
Study Phase : Phase IV
Sponsor : Baker Heart and Diabetes Institute
Deal Size : Inapplicable
Deal Type : Inapplicable
Eplerenone in the Management of Abdominal Aortic Aneurysms
Details : Undisclosed
Product Name : Undisclosed
Product Type : Other Small Molecule
Upfront Cash : Inapplicable
January 26, 2015
Lead Product(s) : Eplerenone
Therapeutic Area : Cardiology/Vascular Diseases
Highest Development Status : Phase IV
Sponsor : Baker Heart and Diabetes Institute
Deal Size : Inapplicable
Deal Type : Inapplicable
Lead Product(s) : Eplerenone
Therapeutic Area : Cardiology/Vascular Diseases
Study Phase : Phase IV
Sponsor : Pfizer Inc
Deal Size : Inapplicable
Deal Type : Inapplicable
The Effects of Eplerenone on Markers of Myocardial Fibrosis in Adult Congenital Heart Disease
Details : Undisclosed
Product Name : Undisclosed
Product Type : Other Small Molecule
Upfront Cash : Inapplicable
October 29, 2013
Lead Product(s) : Eplerenone
Therapeutic Area : Cardiology/Vascular Diseases
Highest Development Status : Phase IV
Sponsor : Pfizer Inc
Deal Size : Inapplicable
Deal Type : Inapplicable
Lead Product(s) : Eplerenone
Therapeutic Area : Cardiology/Vascular Diseases
Study Phase : Phase III
Sponsor : University Medical Center Groningen | The Interuniversity Cardiology Institute of the Netherlands | ZonMw | Netherlands: CVON, CardioVascular Research Netherlands
Deal Size : Inapplicable
Deal Type : Inapplicable
PHOspholamban RElated CArdiomyopathy STudy - Intervention
Details : Undisclosed
Product Name : Undisclosed
Product Type : Other Small Molecule
Upfront Cash : Inapplicable
May 20, 2013
Lead Product(s) : Eplerenone
Therapeutic Area : Cardiology/Vascular Diseases
Highest Development Status : Phase III
Sponsor : University Medical Center Groningen | The Interuniversity Cardiology Institute of the Netherlands | ZonMw | Netherlands: CVON, CardioVascular Research Netherlands
Deal Size : Inapplicable
Deal Type : Inapplicable
Lead Product(s) : Eplerenone
Therapeutic Area : Oncology
Study Phase : Phase II/ Phase III
Sponsor : Canadian Cancer Society | Pfizer Inc
Deal Size : Inapplicable
Deal Type : Inapplicable
Details : Undisclosed
Product Name : Undisclosed
Product Type : Other Small Molecule
Upfront Cash : Inapplicable
October 17, 2012
Lead Product(s) : Eplerenone
Therapeutic Area : Oncology
Highest Development Status : Phase II/ Phase III
Sponsor : Canadian Cancer Society | Pfizer Inc
Deal Size : Inapplicable
Deal Type : Inapplicable
Lead Product(s) : Eplerenone
Therapeutic Area : Cardiology/Vascular Diseases
Study Phase : Phase III
Sponsor : Pfizer Inc
Deal Size : Inapplicable
Deal Type : Inapplicable
Details : Undisclosed
Product Name : Undisclosed
Product Type : Other Small Molecule
Upfront Cash : Inapplicable
April 26, 2012
Lead Product(s) : Eplerenone
Therapeutic Area : Cardiology/Vascular Diseases
Highest Development Status : Phase III
Sponsor : Pfizer Inc
Deal Size : Inapplicable
Deal Type : Inapplicable